Newsroom

For media inquiries, please contact 340B Health Senior Vice President of Communications Jon Tilton at jon.tilton@340bhealth.org​​​​​​​ or 202-536-2285.

• STATEMENT ON BRISTOL MYERS SQUIBB RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES

  January 18, 2022 in 340B Health News Releases

• STATEMENT ON ABBVIE RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES

  December 30, 2021 in 340B Health News Releases

• 340B HEALTH PRAISES GOVERNMENT APPEALS OF COURT DECISIONS ON COMMUNITY PHARMACIES

  December 28, 2021 in 340B Health News Releases

• MORE THAN 800 HOSPITALS URGE GOVERNMENT TO APPEAL COURT DECISION ON 340B COMMUNITY PHARMACIES

  December 20, 2021 in 340B Health News Releases

• STATEMENT ON AMGEN RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES

  December 01, 2021 in 340B Health News Releases

• STATEMENT ON UCB RESTRICTING 340B DISCOUNTS THROUGH COMMUNITY-BASED PHARMACIES

  November 23, 2021 in 340B Health News Releases

• As Big Pharma and Hospitals Battle Over Drug Discounts, Patients Miss Out on Millions in Benefits

  November 16, 2021 in 340B in the News

• STATEMENT ON FEDERAL COURT OPINION IN NOVARTIS AND UNITED THERAPEUTICS 340B COMMUNITY PHARMACY LAWSUITS

  November 06, 2021 in 340B Health News Releases

• STATEMENT ON FEDERAL COURT OPINION IN SANOFI AND NOVO NORDISK 340B COMMUNITY PHARMACY LAWSUITS

  November 05, 2021 in 340B Health News Releases

• REPORT: 340B HOSPITALS ARE DIRECTING SAVINGS TOWARD THEIR COMMUNITIES’ UNIQUE NEEDS

  November 03, 2021 in 340B Health News Releases

• STATEMENT ON MEDICARE PAYMENT CUTS TO 340B HOSPITALS IN 2022

  November 02, 2021 in 340B Health News Releases

• STATEMENT ON FEDERAL COURT OPINION IN 340B COMMUNITY PHARMACY LAWSUIT

  October 30, 2021 in 340B Health News Releases